JIM GLASHEEN

Profile

First Name

: JIM

Middle Name

:

Last Name

: GLASHEEN

Related Companies

Titles

Company Name

Related People

DIRECTOR

TRANSCEND MEDICAL INC

ROBERT BELLAS, JR., ROBERT C. BELLAS, JR., EUGENE DE JUAN, JR., M.D., DAN GALLES, WENDE HUTTON, TSONTCHO IANCHULEV, ABHIJEET LELE, K. ANGELA MACFARLANE, DAVID STASSEN, DAVID W. STASSEN, ART TAYLOR, BRIAN WALSH, AL WIEGMAN, REZA ZADNO, EVGENY ZAYTSEV

DIRECTOR

REVANCE THERAPEUTICS, INC.

DANIEL L. BROWNE, L. DANIEL BROWNE, ROBERT BYRNES, RON EASTMAN, RONALD EASTMAN, PHYLLIS GARDNER, FRANK KUNG, VICENTE TRELLES, JONATHAN TUNNICLIFFE

DIRECTOR

INCLINE THERAPEUTICS, INC.

JAMES GLASHEEN, PH.D., TERRY GOULD, ALAN LEVY, PH.D., THEODORE R. SCHROEDER, DAVID SOCKS, DAVID A. SOCKS, JAMES TOPPER, JAMES TOPPER, M.D., PH.D., JIM YOUNG, JAMES W. YOUNG, PH.D.

DIRECTOR

ELCELYX THERAPEUTICS, INC.

ALAIN BARON, ALAIN D. BARON, RICHARD BARRY, RICHARD J. BARRY, MARTIN R. BROWN, BROOK BYERS, RALPH E. CHRISTOFFERSEN, RALPH E. CHRISTOFFERSON, MARK FINEMAN, GINGER GRAHAM, BOSUN HAU, CHRISTOPHER R. G. JONES, THEODORE A. LAUFIK, SANDY MAHATME, CHRISTOFFERSEN RALPH, JAY SHERWOOD, LIANG TSUI, MARK WIGGINS

DIRECTOR

FORSIGHT VISION5, INC.

ROBERT C. BELLAS, JR., ANDY CORLEY, AARON DAVIDSON, EUGENE DE JUAN, JR., M.D., HANSON S. GIFFORD III, WILLIAM J. LINK, PH.D, WILLIAM J. LINK, PH.D., K. ANGELA MACFARLANE, JOHN F. MARONEY, FEROLYN POWELL, CHARLES M. WARDEN

EXECUTIVE OFFICER, DIRECTOR

CLADE THERAPEUTICS, INC.

CHAD A. COWAN, MARTIN MURPHY, DANIEL VASELLA, LEANDRO VETCHER, NEIL WHITE

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2021-12-17

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2021-08-11

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2018-10-24

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2015-08-24

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2015-08-24

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2015-09-25

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2015-08-24

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2015-02-04

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2014-03-21

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2014-04-15

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2014-03-21

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-02-13

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity, Debt

2013-10-08

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2013-04-05

D/A

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2013-04-05

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2013-04-05

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2013-02-13

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2013-02-05

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2011-01-24

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-01-11

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2011-01-24

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-01-11

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

2011-09-20

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Equity

2011-06-30

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2011-01-24

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2011-01-11

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2011-01-24

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2009-12-08

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2009-12-08

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2009-12-08

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2009-12-23

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2009-12-08

D/A

OTHER

DECLINE TO DISCLOSE

Equity

2009-05-22

D

OTHER

DECLINE TO DISCLOSE

Equity

2009-05-22